<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Gas Res</journal-id><journal-id journal-id-type="publisher-id">MGR</journal-id><journal-id journal-id-type="publisher-id">Med Gas Res</journal-id><journal-title-group><journal-title>Medical Gas Research</journal-title></journal-title-group><issn pub-type="epub">2045-9912</issn><publisher><publisher-name>Wolters Kluwer - Medknow</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC466995</article-id><article-id pub-id-type="publisher-id">MGR-14-96</article-id><article-id pub-id-type="doi">10.4103/2045-9912.385946</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>The role of nitric oxide and hydrogen sulfide in spinal cord injury: an updated review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wen</surname><given-names>Xiaoliang</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="fn1" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Yang</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="fn1" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Zhengquan</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Shen</surname><given-names>Haitao</given-names></name><degrees>MM</degrees><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9296-3725</contrib-id><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Cui</surname><given-names>Gang</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4788-8057</contrib-id><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Gang</given-names></name><xref rid="aff1" ref-type="aff"/></contrib></contrib-group><aff id="aff1">Brain and Nerve Research Laboratory, Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China</aff><author-notes><corresp id="cor1"><label>*</label>Correspondence to: Haitao Shen, <email xlink:href="shenhaitao1990@suda.edu.cn">shenhaitao1990@suda.edu.cn</email>; Gang Cui, <email xlink:href="2445133252@qq.com">2445133252@qq.com</email>.</corresp><fn id="fn1"><label>#</label><p>Both authors contributed equally to this work.</p></fn><fn fn-type="con"><p>
<bold>Author contributions</bold>
</p><p>Study design: GC, HS, XW; literature search, manuscript preparation and writing: XW; manuscript revision and editing: YY, ZY, GC; figures and tables preparation: XW, YY; manuscript review: GC, HS. All authors approved the final manuscript for publication.</p></fn></author-notes><pub-date pub-type="collection"><season>Jul-Sep</season><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>9</month><year>2023</year></pub-date><volume>14</volume><issue>3</issue><fpage>96</fpage><lpage>101</lpage><history><date date-type="received"><day>05</day><month>9</month><year>2022</year></date><date date-type="rev-recd"><day>16</day><month>12</month><year>2022</year></date><date date-type="accepted"><day>04</day><month>4</month><year>2023</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2024 Medical Gas Research</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><p>Medical gases play an important role in the pathophysiology of human diseases and have received extensive attention for their role in neuroprotection. Common pathological mechanisms of spinal cord injury include excitotoxicity, inflammation, cell death, glial scarring, blood-spinal cord barrier disruption, and ischemia/reperfusion injury. Nitric oxide and hydrogen sulfide are important gaseous signaling molecules in living organisms; their pathological role in spinal cord injury models has received more attention in recent years. This study reviews the possible mechanisms of spinal cord injury and the role of nitric oxide and hydrogen sulfide in spinal cord injury.</p></abstract><kwd-group><kwd>central nervous system</kwd><kwd>excitotoxicity</kwd><kwd>hydrogen sulfide</kwd><kwd>ischemia/reperfusion injury</kwd><kwd>medical gas</kwd><kwd>nitric oxide</kwd><kwd>secondary injury</kwd><kwd>spinal cord injury</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>I<sc>NTRODUCTION</sc></title><p>Spinal cord injury (SCI) is defined as motor, sensory, and autonomic dysfunction in the injured segment caused by a variety of factors; it has a high rate of death and disability. Over the past few decades, the global prevalence of SCI has risen among individuals, estimated to range from 250,000 to 500,000 people each year.<xref rid="R1" ref-type="bibr">1</xref><xref rid="R2" ref-type="bibr">2</xref> SCI not only brings serious financial burden but also psychological pressure to patients.<xref rid="R3" ref-type="bibr">3</xref> There is a lack of effective methods to treat SCI, and exploring treatment modalities for SCI was important.<xref rid="R4" ref-type="bibr">4</xref></p><p>Neuroprotective properties have been observed with certain medicinal gases, common gases including hydrogen sulfide (H<sub>2</sub>S), nitric oxide (NO), volatile and non-volatile anesthetics also evidence suggests they are potential neuroprotective agents.<xref rid="R5" ref-type="bibr">5</xref> According to research, gas transmitters, also known as biogaseous gas molecules, have significant impacts on the pathological conditions of mammals.<xref rid="R6" ref-type="bibr">6</xref> For instance, drinking hydrogen-rich water has been found to effectively reduce hepatic oxidative stress, apoptosis, inflammation, and hepatocarcinogenesis, making it a potential treatment for alcoholic hepatitis.<xref rid="R7" ref-type="bibr">7</xref> Supplementation of H<sub>2</sub>S in rectal cancer avoids the loss of resistance to 5-fluorouracil induced by cystine-glutamate antiporter interference, that suggesting a functional role for H<sub>2</sub>S in the maintenance of chemoresistance.<xref rid="R8" ref-type="bibr">8</xref> Gas molecules play an important role in various pathophysiological states, which are of great significance for clinical treatment.</p><p>Over the past few years, research on the increasing attention given to the involvement of gas molecules in SCI has been growing, even though their mechanisms of action are not identical. An in-depth exploration of the correlation between medical gas and SCI has the potential to expand the horizon, inform SCI treatment approaches, open new avenues for therapeutic interventions, and reduce the pain and economic burden of SCI patients. In this article, We will review the pathomechanisms of SCI and the research progress on the role of NO and H<sub>2</sub>S in SCI. We searched PubMed for nearly 20 years of research primarily by the keywords &#x0201c;spinal cord injury and pathology&#x0201d; or &#x0201c;spinal cord injury and nitric oxide&#x0201d; or &#x0201c;spinal cord injury and hydrogen sulfide.&#x0201d;</p></sec><sec id="sec1-2"><title>P<sc>HYSIOLOGICAL AND</sc> P<sc>ATHOLOGICAL</sc> M<sc>ECHANISMS OF</sc> S<sc>PINAL</sc> C<sc>ORD</sc> I<sc>NJURY</sc></title><p>The first stage of SCI is mechanical damage caused by temporary or permanent compression and crushing.<xref rid="R9" ref-type="bibr">9</xref><xref rid="R10" ref-type="bibr">10</xref> The second stage primarily involves the destruction and death of related tissues in the spinal cord, which includes complex pathophysiological mechanisms.<xref rid="R11" ref-type="bibr">11</xref><xref rid="R12" ref-type="bibr">12</xref><xref rid="R13" ref-type="bibr">13</xref> The mechanism of SCI is intricate, and understanding the molecular mechanism of SCI is crucial to its treatment. Here, we will discuss the related mechanisms after SCI (<bold><xref rid="F1" ref-type="fig">Figure 1</xref></bold>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Pathological manifestations of spinal cord injury.</p></caption><graphic xlink:href="MGR-14-96-g001" position="float"/></fig><sec id="sec2-1"><title>Ischemia/reperfusion injury of the spinal cord</title><p>Ischemia often occurs at the injury site following SCI. Ischemia/reperfusion (I/R) injury is one of the pathological changes recognized and studied by many researchers. Neurons in the spinal cord have a higher basal metabolism and are more susceptible to damage leading to cell death during ischemia. Large intracellular glutamate efflux after neuronal apoptosis, resulting in glutamate amino acid excitotoxicity.<xref rid="R14" ref-type="bibr">14</xref><xref rid="R15" ref-type="bibr">15</xref><xref rid="R16" ref-type="bibr">16</xref><xref rid="R17" ref-type="bibr">17</xref> Restoration of blood flow after I/R in SCI stimulates the expression of adhesion molecules and chemokines, leading to changes in the immune-inflammatory microenvironment by activating immune cells such as microglia, astrocytes, and macrophages.<xref rid="R18" ref-type="bibr">18</xref> Cytotoxic, ionic, and vasogenic factors contribute to spinal cord ischemia-induced edema.<xref rid="R1" ref-type="bibr">1</xref> Progress has been made in alleviating spinal cord I/R injury, but it remains a challenge in clinical treatment.<xref rid="R19" ref-type="bibr">19</xref> I/R injuries often have serious consequences, including motor and sensory dysfunction and autonomic dysfunction.<xref rid="R20" ref-type="bibr">20</xref></p></sec><sec id="sec2-2"><title>Excitotoxicity of SCI</title><p>The vital role in the advancement of central nervous system disorders is attributed to excitotoxicity induced by glutamate.<xref rid="R21" ref-type="bibr">21</xref><xref rid="R22" ref-type="bibr">22</xref> Glutamate receptor activation after SCI substantially elevates glutamate levels, resulting in continuous excito-toxicity and cell death.<xref rid="R23" ref-type="bibr">23</xref> Excessive glutamate release and impaired uptake following traumatic SCI cause neurotoxic concentrations around the injury site.<xref rid="R24" ref-type="bibr">24</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref> Consequently, the neuronal ion pump is compromised, allowing an influx of Ca<sup>2+</sup> into the neuron and inflicting direct and indirect spinal cord damage. Intracellular calcium overload triggers cell death via calpain activation, reactive oxygen species production, and mitochondrial impairment.<xref rid="R27" ref-type="bibr">27</xref> Additionally, calcium overload stimulates protein kinases and phospholipases, contributing to calpain-related protein degradation and oxidative harm.<xref rid="R28" ref-type="bibr">28</xref><xref rid="R29" ref-type="bibr">29</xref> Numerous medications targeting excitotoxicity have demonstrated strong effects in SCI animal models. In conclusion, excitotoxicity initiates a series of pathophysiological alterations and cascades after SCI, encompassing mitochondrial dysfunction, cytoskeleton disruption, free radical generation, axonal degeneration, glutamate release, and eventually apoptotic or necrotic cascade reactions within the pathway.<xref rid="R30" ref-type="bibr">30</xref></p></sec><sec id="sec2-3"><title>Free radical of SCI</title><p>A larger number of studies indicate that early pathological changes in SCI include overproduction of reactive oxygen species and reactive nitrogen species. The generation of reactive oxygen specie and reactive nitrogen species during SCI mainly results from increased intracellular calcium levels, arachidonic acid metabolism, and activation of inducible nitric oxide synthase. The central nervous system is particularly vulnerable to damage caused by free radicals, and the excessive production of reactive oxygen specie and reactive nitrogen species leads to oxidative and nitrative harm to lipids, proteins, and nucleic acids. Free radicals not only disrupt neuronal cell membranes but also damage the cytoskeleton and organelles. Oxidative stress damage exacerbates mitochondrial dysfunction, intracellular calcium overload, activates proteases and leads to cytoskeletal proteolysis.<xref rid="R13" ref-type="bibr">13</xref><xref rid="R31" ref-type="bibr">31</xref> Excessive free radicals can also lead to DNA damage and cellular aging.<xref rid="R32" ref-type="bibr">32</xref><xref rid="R33" ref-type="bibr">33</xref></p></sec><sec id="sec2-4"><title>Glial scar formation after SCI</title><p>Glial scarring or gliosis, is an astrocyte-driven cellular response triggered under pathological conditions. Activated monocytes-macrophages, fibroblasts, and extracellular matrix proteins become part of the core of the lesion.<xref rid="R34" ref-type="bibr">34</xref> Following SCI, astrocytes undergo proliferation, hypertrophy, and gradual migration along the periphery of extensively damaged tissue, intertwining around the core of the lesion and forming the primary component of the glial scar.<xref rid="R35" ref-type="bibr">35</xref><xref rid="R36" ref-type="bibr">36</xref><xref rid="R37" ref-type="bibr">37</xref> The glial scar hinders axon regeneration by creating a physical obstacle that prevents axons from crossing the lesion area.<xref rid="R38" ref-type="bibr">38</xref> The principal chemical constituents of glial scars are chondroitin sulfate proteoglycans. These components are predominantly expressed by reactive astrocytes and can significantly restrict axonal regeneration after SCI, as well as sprouting and remyelination.<xref rid="R39" ref-type="bibr">39</xref><xref rid="R40" ref-type="bibr">40</xref><xref rid="R41" ref-type="bibr">41</xref> Protein tyrosine phosphatases are receptors for chondroitin sulfate proteoglycan and inhibit axonal regeneration when bound to chondroitin sulfate proteoglycan.<xref rid="R42" ref-type="bibr">42</xref><xref rid="R43" ref-type="bibr">43</xref> Nonetheless, a membrane-permeable peptidomimetic that blocks this receptor not only reduces inhibition of axonal regeneration but also enhances the restoration of motor and urinary system functionality.<xref rid="R42" ref-type="bibr">42</xref></p><p>But there is also recent evidence from different studies that glial scarring promotes axonal growth in the early stages of injury. Glial scarring protects normal tissues from neurotoxicity and excitotoxicity by restricting inflammatory factors and toxic substances to areas of damaged tissue.<xref rid="R1" ref-type="bibr">1</xref> The intricate mechanisms of glial scarring in SCI have increasingly garnered attention, necessitating further research to comprehensively and profoundly comprehend its pros and cons.</p></sec><sec id="sec2-5"><title>Neuroinflammation and SCI</title><p>During traumatic SCI, peripheral inflammatory cells infiltrate and activate central inflammatory cells, initiating cascade reactions and releasing pro-inflammatory factors (such as interferon-gamma, tumor necrosis factor alpha, interleukin-1, interleukin-6, interleukin-8 and interleukin-12).<xref rid="R44" ref-type="bibr">44</xref> In some cases, these inflammatory cells play a favorable role in SCI, but as the injury progresses, the continuous production of inflammatory factors can have effects on the body. Neutrophils, macrophages, and lymphocytes migrate to the injured spinal cord. The site, where microglia are also activated. Neutrophils migrate to the injured area rapidly, peaking after 24 hours, and gradually decreasing after 1 week.<xref rid="R45" ref-type="bibr">45</xref> They engulf foreign cells and remove debris while also activating various inflammatory cells and microglia in tissues to accelerate neuronal destruction, which is considered detrimental. Rossignol et al.<xref rid="R46" ref-type="bibr">46</xref> suggest that altering the external conditions can control the secondary inflammatory response in a direction beneficial to spinal cord repair; otherwise, the inflammatory response will accelerate cell necrosis and hinder axonal growth. The effect of neutrophils in SCI has been studied more recently, and some studies have said that it can play a role in tissue repair by reducing inflammation. For example, the release of secretory leukocyte protease inhibitors reduces inflammation and promotes axonal regeneration.<xref rid="R47" ref-type="bibr">47</xref> Microglia are mainly polarized to the M1 phenotype after SCI, and polarized M1 amoeboid cells change with the release of neurotoxic substances, leading to neuronal damage. M2-polarized microglia undergo phenotypic changes that enable them to promote nerve regeneration, especially axon extension, after central nervous system injury.<xref rid="R48" ref-type="bibr">48</xref></p></sec></sec><sec id="sec1-3"><title>T<sc>HE</sc> R<sc>OLE OF</sc> N<sc>ITRIC</sc> O<sc>XIDE IN</sc> S<sc>PINAL</sc> C<sc>ORD</sc> I<sc>NJURY</sc></title><p>NO is a widespread and important biomolecule involved in many physiological processes in mammalian life activities. Its production in the body is catalyzed by NO synthase under specific conditions. There are three types of NO synthases: endothelial NO synthase, neurogenic NO synthase (nNOS), and inducible NO synthase (iNOS). nNOS is mainly found in the central and peripheral nervous systems, endothelial NO synthase is expressed in cerebral vascular endothelial cells, and iNOS is expressed during inflammation.<xref rid="R49" ref-type="bibr">49</xref> This subsection provides a review of the mechanisms of action of NO and NOS in SCI (<bold><xref rid="T1" ref-type="table">Table 1</xref></bold>).<xref rid="R50" ref-type="bibr">50</xref><xref rid="R51" ref-type="bibr">51</xref><xref rid="R52" ref-type="bibr">52</xref><xref rid="R53" ref-type="bibr">53</xref><xref rid="R54" ref-type="bibr">54</xref><xref rid="R55" ref-type="bibr">55</xref><xref rid="R56" ref-type="bibr">56</xref></p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Main experimental studies of NO and NOS in SCI rat models</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Study</th><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Animals/cells</th><th align="left" rowspan="1" colspan="1">Conclusion</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Li et al.<xref rid="R50" ref-type="bibr">50</xref></td><td align="left" rowspan="1" colspan="1">SCI</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">iNOS is involved in neuronal apoptosis after spinal cord ischemia-reperfusion injury via dephosphorylation of phospho-Bad (a proapoptotic Bcl-2 family protein).</td></tr><tr><td align="left" rowspan="1" colspan="1">Hamada et al.<xref rid="R51" ref-type="bibr">51</xref></td><td align="left" rowspan="1" colspan="1">SCI</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">NO produced by iNOS may be neurotoxic in the subacute phase after SCI.</td></tr><tr><td align="left" rowspan="1" colspan="1">Est&#x000e9;vez et al.<xref rid="R52" ref-type="bibr">52</xref></td><td align="left" rowspan="1" colspan="1">SCI</td><td align="left" rowspan="1" colspan="1">Neuronal cells</td><td align="left" rowspan="1" colspan="1">Peroxynitrite, a strong oxidant formed by NO and superoxide, induces apoptosis of motor neurons.</td></tr><tr><td align="left" rowspan="1" colspan="1">Wang et al.<xref rid="R53" ref-type="bibr">53</xref></td><td align="left" rowspan="1" colspan="1">Spinal root- avulsion</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">Upregulation of the nNOS protein prevents motor neuron degeneration in a radicular avulsion injury.</td></tr><tr><td align="left" rowspan="1" colspan="1">Xu et al.<xref rid="R54" ref-type="bibr">54</xref></td><td align="left" rowspan="1" colspan="1">SCI</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">iNOS-induced NO, through nitration of tyrosine residues, damages cell membranes and organelles.</td></tr><tr><td align="left" rowspan="1" colspan="1">Kiziltepe et al.<xref rid="R55" ref-type="bibr">55</xref></td><td align="left" rowspan="1" colspan="1">SCI</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">The neuroprotection of resveratrol may be mediated by its antioxidant and NO properties.</td></tr><tr><td align="left" rowspan="1" colspan="1">Chen et al.<xref rid="R56" ref-type="bibr">56</xref></td><td align="left" rowspan="1" colspan="1">SCI</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">NO generated by nNO attenuates spinal cord injury transmission and neuropathic pain</td></tr></tbody></table><table-wrap-foot><fn id="TF-F1"><p>Note: iNOS: Inducible NO synthase; nNOS: neurogenic NO synthase; NO: nitric oxide; SCI: spinal cord injury.</p></fn></table-wrap-foot></table-wrap><p>Many studies have found the role of NO in central nervous system diseases, but its potential role and mechanism in SCI are not very clear.<xref rid="R50" ref-type="bibr">50</xref><xref rid="R51" ref-type="bibr">51</xref><xref rid="R57" ref-type="bibr">57</xref> As mentioned above, oxidative damage is one of the important pathological changes in secondary SCI. Currently, in a post-SCI study in rats, it was found that after treatment with NOS inhibitor, the movement disorders of the hindlimbs of the rats with SCI were significantly increased, and the concentration of thiobarbituric acid reactive substances and the level of myeloperoxidase activity was also significantly increased, indicating that the formation of NO by constitutive NOS has an effect on the cell damage after SCI. It was also observed that iNOS-induced NO might exhibit neurotoxic properties during the subacute phase following SCI.<xref rid="R51" ref-type="bibr">51</xref></p><p>Physiological levels of NO are not highly toxic, but elevated concentrations can lead to neurological damage. Nitrite formed by the reaction of NO with O<sub>2</sub> is highly oxidizing and can oxidize lipids, DNA and proteins, ultimately inducing apoptosis in neuronal cells.<xref rid="R52" ref-type="bibr">52</xref> In a study involving spinal radicular avulsion injury in adult male rats, inhibiting c-jun phosphorylation prevented nNOS levels in the spinal cord from dropping below baseline levels and partially alleviated motor neuron death post-injury,<xref rid="R53" ref-type="bibr">53</xref> suggesting that nNOS-derived NO may mitigate neuronal damage after SCI, although the underlying mechanism remains unclear.</p><p>Secondary tissue damage following SCI might be attributed to inflammatory mediators. In SCI and other pathological conditions affecting the CNS, excess NO produced by activation of iNOS by nuclear factor-kappaB transcription factor promotes an inflammatory response with cytotoxic effects, leading to neuronal apoptosis.<xref rid="R54" ref-type="bibr">54</xref><xref rid="R58" ref-type="bibr">58</xref> Cell membrane lipid peroxidation and loss of membrane function can result in apoptosis.<xref rid="R57" ref-type="bibr">57</xref> However, research has demonstrated that during SCI, resveratrol can upregulate NO, inhibit membrane lipid peroxidation, scavenge oxygen free radicals, inhibit platelet aggregation, and protect multiple organs from I/R injury.<xref rid="R55" ref-type="bibr">55</xref></p><p>Pain hypersensitivity induced by spinal nerve injury has gained increasing attention in recent times. Spinal N-methyl-D-aspartate receptors are closely related to chronic pain caused by peripheral nerve injury. Studies have shown that endogenous NO inhibits the activity of spinal cord N-methyl-D-aspartate receptors through S-nitrosylation, and the NO generated by nNOS can reduce spinal cord nociceptive transmission and neuropathic pain caused by nerve injury.<xref rid="R56" ref-type="bibr">56</xref> It is not entirely clear which type of NOS is responsible for the pathological increase in NO production in SCI. The initial maximum increase in NO may be caused by nNOS, while the second wave of NO production may be caused by iNOS. Some researchers have found that NO produced by iNOS can have neurotoxic effects.<xref rid="R51" ref-type="bibr">51</xref></p><p>At present, there is no unified conclusion on the changes of different NOS after SCI and the effect and mechanism of NO produced on neuroprotection and cytotoxicity to convince everyone. Analysis of the temporal distribution and cellular origin of the activation of different synthase isoforms to reduce NO-induced damage by inhibiting specific synthases is also the focus of our research.<xref rid="R59" ref-type="bibr">59</xref> A lot of research is still needed to discover their specific potential effects, and it is possible to find New therapeutic targets to improve functional recovery after SCI in patients in the clinic.</p></sec><sec id="sec1-4"><title>T<sc>HE</sc> R<sc>OLE OF</sc> H<sc>YDROGEN</sc> S<sc>ULFIDE IN</sc> S<sc>PINAL</sc> C<sc>ORD</sc> I<sc>NJURY</sc></title><p>H<sub>2</sub>S smells like rotten eggs and has been considered a toxic gas since its discovery. Studies have found that H<sub>2</sub>S is widely present in cardiovascular, nervous, gastrointestinal, respiratory, renal, liver, and reproductive systems, and plays a role in the body&#x02019;s pathological and physiological processes.<xref rid="R60" ref-type="bibr">60</xref> This subsection provides a review of the mechanisms of action of H<sub>2</sub>S in SCI (<bold><xref rid="T2" ref-type="table">Table 2</xref></bold>).<xref rid="R61" ref-type="bibr">61</xref><xref rid="R62" ref-type="bibr">62</xref><xref rid="R63" ref-type="bibr">63</xref> H<sub>2</sub>S is synthesized primarily by cysteine &#x003b2;-synthase and cysteine &#x003b3;-lyase. Cysteine &#x003b2;-synthase is mainly found in the central nervous system and is currently considered to be H<sub>2</sub>S synthase and plays an important role in central nervous system pathophysiology.<xref rid="R64" ref-type="bibr">64</xref><xref rid="R65" ref-type="bibr">65</xref> H<sub>2</sub>S is a gas endogenous signaling molecule that can better pass through various biological barriers, regulate the expression of different types of microRNAs, and participate in the regulation of different signaling pathways in physiological and pathological processes. In the rat SCI model, H<sub>2</sub>S was found to be neuroprotective, ameliorating symptoms and reducing inflammatory factor secretion, neuronal apoptosis, endoplasmic reticulum, and oxidative stress in rats.<xref rid="R61" ref-type="bibr">61</xref><xref rid="R62" ref-type="bibr">62</xref></p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Main experimental studies of H<sub>2</sub>S in SCI</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Study</th><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Animals/cells</th><th align="left" rowspan="1" colspan="1">Conclusion</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Xu et al.<xref rid="R61" ref-type="bibr">61</xref></td><td align="left" rowspan="1" colspan="1">SCI</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">Reduces inflammatory factors, apoptosis, and oxidative stress by activating factor-erythroid 2-related factor 2 protein.</td></tr><tr><td align="left" rowspan="1" colspan="1">Xie et al.<xref rid="R62" ref-type="bibr">62</xref></td><td align="left" rowspan="1" colspan="1">SCIR</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">Inhibited autophagic cell death significantly by reducing oxidative stress via the AKT/mTOR pathway.</td></tr><tr><td align="left" rowspan="1" colspan="1">Liu et al.<xref rid="R63" ref-type="bibr">63</xref></td><td align="left" rowspan="1" colspan="1">SCI</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">Protects the spinal cord by upregulating CasC7 expression in the SCI rat model.</td></tr><tr><td align="left" rowspan="1" colspan="1">Li et al.<xref rid="R66" ref-type="bibr">66</xref></td><td align="left" rowspan="1" colspan="1">SCIR</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">Protects the spinal cord and induces autophagy through miR-30c.</td></tr><tr><td align="left" rowspan="1" colspan="1">Yang et al.<xref rid="R67" ref-type="bibr">67</xref></td><td align="left" rowspan="1" colspan="1">SCI</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">Reduce bone loss caused by SCI and improve motor function of the extremities.</td></tr><tr><td align="left" rowspan="1" colspan="1">Kakino et al.<xref rid="R68" ref-type="bibr">68</xref></td><td align="left" rowspan="1" colspan="1">Transient spinal cord ischemia</td><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">Interacts with NO to exert anti-apoptosis and improve delayed paraplegia.</td></tr><tr><td align="left" rowspan="1" colspan="1">Wang et al.<xref rid="R69" ref-type="bibr">69</xref><break/>Campolo et al.<xref rid="R70" ref-type="bibr">70</xref></td><td align="left" rowspan="1" colspan="1">SCI</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">Anti-oxidative stress and anti-inflammatory effects exert neuroprotection.</td></tr></tbody></table><table-wrap-foot><fn id="TF-F2"><p>Note: CasC7: Cancer susceptibility candidate 7; H<sub>2</sub>S: hydrogen sulfide; mTOR: mammalian target of rapamycin; NO: nitric oxide; SCI: spinal cord injury; SCIR: spinal cord ischemia/reperfusion.</p></fn></table-wrap-foot></table-wrap><p>As mentioned earlier, I/R injury after SCI is an important cause of tissue necrosis and apoptosis, and neurons cannot be regenerated.<xref rid="R71" ref-type="bibr">71</xref> Therefore, the occurrence of cell necrosis after injury will cause serious consequences, and minimizing spinal cord I/R injury has become a research hotspot of SCI and has received more and more attention. Liu et al.<xref rid="R63" ref-type="bibr">63</xref> found that NaHS treatment in a rat spinal cord ischemia model can reduce spinal cord neuron apoptosis and infarct size, which is mainly related to NaSH downregulating miR-30. Autophagy is a process of degradation and recycling of intracellular cytoplasm, long-lived proteins, and organelles. Numerous studies have found that autophagy has two sides in the pathological process, which can play a cytoprotective role and also can lead to cell death.<xref rid="R72" ref-type="bibr">72</xref><xref rid="R73" ref-type="bibr">73</xref><xref rid="R74" ref-type="bibr">74</xref> Xie et al.<xref rid="R62" ref-type="bibr">62</xref> found that autophagy promoted neuronal cell death after spinal cord I/R, and H<sub>2</sub>S reduced I/R through the Akt/mammalian target of the rapamycin pathway in animal experiments. Interestingly, Li et al.<xref rid="R66" ref-type="bibr">66</xref> found that H<sub>2</sub>S increased cellular autophagy to protect the spinal cord from I/R injury by inhibiting miR-30c expression and upregulating the expression of autophagy-related proteins. This may be related to the duration of H<sub>2</sub>S action <italic toggle="yes">in vitro</italic>, the route of administration, and the protective mechanism of H<sub>2</sub>S in spinal cord I/R injury needs further study.</p><p>Both inflammation and oxidative stress are key factors in SCI and secondary injury. Glutathione is a reducing agent in the body, scavenging oxygen free radicals, hydrogen peroxide, and lipid peroxides in the central nervous system. H<sub>2</sub>S promotes glutathione synthesis and protects neurons from oxidative stress damage.<xref rid="R75" ref-type="bibr">75</xref> Nuclear factor-e2-related factor 2 (Nrf2) is a widely distributed protein in tissues and organs, acting as a crucial regulator of cellular redox responses.<xref rid="R76" ref-type="bibr">76</xref> The activation of Nrf2 enhances the antioxidative stress capacity of neuronal cells, thus providing neuroprotective functions. Research has demonstrated that in a mouse SCI model, NaHS treatment significantly ameliorated the neurological recovery of injured mice, potentially due to the activation of Nrf2 signaling molecules, increased nuclear translocation of Nrf2, and subsequent activation of downstream target genes that play roles in SCI, including anti-inflammatory, antioxidant, and neuroprotective effects.<xref rid="R61" ref-type="bibr">61</xref> SCI leads to the disruption of the blood-spinal cord barrier. A study by Wang et al.<xref rid="R69" ref-type="bibr">69</xref> discovered that NaHS further safeguarded the blood-spinal cord barrier integrity by mitigating inflammatory responses and oxidative stress in a rat SCI model, ultimately enhancing functional recovery after SCI. In another study comparing ATB-346 (an H<sub>2</sub>S-releasing naproxen derivative), naproxen, and a control group, ATB-346 accelerated motor function improvement in a mouse SCI model while significantly reducing inflammation.70 These experimental results support the hypothesis that H2S can reduce oxidative stress and anti-inflammatory effects in SCI. In addition, H<sub>2</sub>S can also reduce bone loss under the lesion caused by SCI in rats, the bone density of the femur and tibia is significantly increased, and the motor function of the limbs is improved.<xref rid="R67" ref-type="bibr">67</xref></p><p>Kakinohana et al.<xref rid="R68" ref-type="bibr">68</xref> found that sulfide prevented spinal ventral horn motor neuron degeneration and delayed paraplegia in mice in an nNOS-dependent manner in a model of spinal cord ischemia. This study found that the protective effect of H<sub>2</sub>S on delayed paraplegia after SCI was mediated by the anti-apoptotic effect of sulfide, which may be achieved through the hyper-sulfation of p65. This study also suggests that p65 hyper-sulfation may promote s-nitrosylation of p65 through nNOS-derived NO hours after reperfusion. The study discovered a new mechanism of action of H<sub>2</sub>S, which provides the possibility for new H<sub>2</sub>S-based therapeutic methods and broadens the therapeutic window of H<sub>2</sub>S.</p><p>The research on H<sub>2</sub>S and other sulfides is still not perfect, and most of them are at the level of experimental animals in the research of SCI. H<sub>2</sub>S has a pungent odor and can be challenging to control inhalation in animal studies, which affects the reliability of experimental results and even causes animal death.<xref rid="R77" ref-type="bibr">77</xref> Therefore, in most experiments, the experimenter adopts a safer and more reliable NaHS intravenous injection method to improve the accuracy of experimental data. However, other studies have shown that the therapeutic index of sulfide is very low and the therapeutic window is very short,<xref rid="R78" ref-type="bibr">78</xref><xref rid="R79" ref-type="bibr">79</xref> which may be one of the reasons why sulfide-based clinical treatments have so far failed to achieve breakthroughs. Currently, different doses, different modes of administration, or different carriers need to be studied to fully study the effect of H<sub>2</sub>S in animal models.</p></sec><sec id="sec1-5"><title>F<sc>UTURE</sc> O<sc>UTLOOK</sc></title><p>Through a large number of studies on animals of SCI, it has been observed that NO and H<sub>2</sub>S are crucial signaling molecules involved in the regulation of disease signaling pathways and play different mechanisms of action in the process of SCI. Its mechanism of action includes improving spinal cord I/R, reducing apoptosis, reducing inflammation, anti-oxidation, and improving angiogenesis and autophagy. Although some studies have found that their effects are not the same in different studies, this may be related to differences in the mode of administration and dosage, mode of action, and type of disease. The limitations of the current studies are that the role of NO and H<sub>2</sub>S in patients is less studied; the lack of drugs targeting NO and H<sub>2</sub>S is one of the great challenges for future research. In conclusion, medical gases, including NO and H<sub>2</sub>S, play an important role in SCI. We believe that medical gases will become a milestone change in the treatment of SCI.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>
<bold>Conflicts of interest</bold>
</p><p>The authors declare that they have no competing interests.</p><p>Editor note: Gang Chen is an Editorial Board member of <italic toggle="yes">Medical Gas Research</italic>. He is blinded from reviewing or making decisions on the manuscript. The article was subject to the journal&#x02019;s standard procedures, with peer review handled independently of this Editorial Board member and his research group.</p></fn><fn fn-type="other"><p>
<bold>Data availability statement</bold>
</p><p>All relevant data are within the paper.</p></fn></fn-group><ref-list><title>R<sc>EFERENCES</sc></title><ref id="R1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anjum</surname><given-names>A</given-names></name>
<name><surname>Yazid</surname><given-names>MD</given-names></name>
<name><surname>Fauzi</surname><given-names>Daud M</given-names></name>
<etal/></person-group><article-title>Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><fpage>7533</fpage><pub-id pub-id-type="pmid">33066029</pub-id>
</element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khorasanizadeh</surname><given-names>M</given-names></name>
<name><surname>Yousefifard</surname><given-names>M</given-names></name>
<name><surname>Eskian</surname><given-names>M</given-names></name>
<etal/></person-group><article-title>Neurological recovery following traumatic spinal cord injury: a systematic review and meta-analysis</article-title><source>J Neurosurg Spine</source><year>2019</year><comment>doi: 10.3171/2018.10.SPINE18802</comment></element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>Z</given-names></name>
<name><surname>Yuan</surname><given-names>S</given-names></name>
<name><surname>Shi</surname><given-names>L</given-names></name>
<etal/></person-group><article-title>Programmed cell death in spinal cord injury pathogenesis and therapy</article-title><source>Cell Prolif</source><year>2021</year><volume>54</volume><fpage>e12992</fpage><pub-id pub-id-type="pmid">33506613</pub-id>
</element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tardivo</surname><given-names>V</given-names></name>
<name><surname>Crobeddu</surname><given-names>E</given-names></name>
<name><surname>Pilloni</surname><given-names>G</given-names></name>
<etal/></person-group><article-title>Say &#x0201c;no&#x0201d; to spinal cord injury: is nitric oxide an option for therapeutic strategies?</article-title><source>Int J Neurosci</source><year>2015</year><volume>125</volume><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">24697508</pub-id>
</element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deng</surname><given-names>J</given-names></name>
<name><surname>Lei</surname><given-names>C</given-names></name>
<name><surname>Chen</surname><given-names>Y</given-names></name>
<etal/></person-group><article-title>Neuroprotective gases--fantasy or reality for clinical use?</article-title><source>Prog Neurobiol</source><year>2014</year><volume>115</volume><fpage>210</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">24440817</pub-id>
</element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>J</given-names></name>
<name><surname>Wu</surname><given-names>PF</given-names></name>
<name><surname>Wang</surname><given-names>F</given-names></name>
<name><surname>Chen</surname><given-names>JG</given-names></name></person-group><article-title>Targeting gaseous molecules to protect against cerebral ischaemic injury: mechanisms and prospects</article-title><source>Clin Exp Pharmacol Physiol</source><year>2012</year><volume>39</volume><fpage>566</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">22150768</pub-id>
</element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kawai</surname><given-names>D</given-names></name>
<name><surname>Takaki</surname><given-names>A</given-names></name>
<name><surname>Nakatsuka</surname><given-names>A</given-names></name>
<etal/></person-group><article-title>Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice</article-title><source>Hepatology</source><year>2012</year><volume>56</volume><fpage>912</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">22505328</pub-id>
</element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>S</given-names></name>
<name><surname>Bu</surname><given-names>D</given-names></name>
<name><surname>Zhu</surname><given-names>J</given-names></name>
<etal/></person-group><article-title>Endogenous hydrogen sulfide regulates xCT stability through persulfidation of OTUB1 at cysteine 91 in colon cancer cells</article-title><source>Neoplasia</source><year>2021</year><volume>23</volume><fpage>461</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">33878705</pub-id>
</element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>DK</given-names></name>
<name><surname>Means</surname><given-names>ED</given-names></name>
<name><surname>Waters</surname><given-names>TR</given-names></name>
<name><surname>Green</surname><given-names>ES</given-names></name></person-group><article-title>Microvascular perfusion and metabolism in injured spinal cord after methylpred-nisolone treatment</article-title><source>J Neurosurg</source><year>1982</year><volume>56</volume><fpage>106</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">7054403</pub-id>
</element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tubbs</surname><given-names>RS</given-names></name>
<name><surname>Blouir</surname><given-names>MC</given-names></name>
<name><surname>Romeo</surname><given-names>AK</given-names></name>
<name><surname>Mortazavi</surname><given-names>MM</given-names></name>
<name><surname>Cohen-Gadol</surname><given-names>AA</given-names></name></person-group><article-title>Spinal cord ischemia and atherosclerosis: a review of the literature</article-title><source>Br J Neurosurg</source><year>2011</year><volume>25</volume><fpage>666</fpage><lpage>670</lpage><pub-id pub-id-type="pmid">21707414</pub-id>
</element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sekhon</surname><given-names>LH</given-names></name>
<name><surname>Fehlings</surname><given-names>MG</given-names></name></person-group><article-title>Epidemiology, demographics, and pathophysiology of acute spinal cord injury</article-title><source>Spine (Phila Pa 1976)</source><year>2001</year><volume>26</volume><fpage>S2</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">11805601</pub-id>
</element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mortazavi</surname><given-names>MM</given-names></name>
<name><surname>Verma</surname><given-names>K</given-names></name>
<name><surname>Deep</surname><given-names>A</given-names></name>
<etal/></person-group><article-title>Chemical priming for spinal cord injury: a review of the literature. Part I-factors involved</article-title><source>Childs Nerv Syst</source><year>2011</year><volume>27</volume><fpage>1297</fpage><lpage>1306</lpage><pub-id pub-id-type="pmid">21170536</pub-id>
</element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oyinbo</surname><given-names>CA</given-names></name></person-group><article-title>Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade</article-title><source>Acta Neurobiol Exp (Wars)</source><year>2011</year><volume>71</volume><fpage>281</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">21731081</pub-id>
</element-citation></ref><ref id="R14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaur</surname><given-names>J</given-names></name>
<name><surname>Mojumdar</surname><given-names>A</given-names></name></person-group><article-title>A mechanistic overview of spinal cord injury, oxidative DNA damage repair and neuroprotective therapies</article-title><source>Int J Neurosci</source><year>2023</year><volume>133</volume><fpage>307</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">33789065</pub-id>
</element-citation></ref><ref id="R15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>S&#x000e1;mano</surname><given-names>C</given-names></name>
<name><surname>Kaur</surname><given-names>J</given-names></name>
<name><surname>Nistri</surname><given-names>A</given-names></name></person-group><article-title>A study of methylprednisolone neuroprotection against acute injury to the rat spinal cord in vitro</article-title><source>Neuroscience</source><year>2016</year><volume>315</volume><fpage>136</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">26701292</pub-id>
</element-citation></ref><ref id="R16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Agrawal</surname><given-names>SK</given-names></name>
<name><surname>Fehlings</surname><given-names>MG</given-names></name></person-group><article-title>Mechanisms of secondary injury to spinal cord axons in vitro: role of Na+, Na(+)-K(+)-ATPase, the Na(+)-H+ exchanger, and the Na(+)-Ca2+ exchanger</article-title><source>J Neurosci</source><year>1996</year><volume>16</volume><fpage>545</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">8551338</pub-id>
</element-citation></ref><ref id="R17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaur</surname><given-names>J</given-names></name>
<name><surname>Flores</surname><given-names>Guti&#x000e9;rrez J</given-names></name>
<name><surname>Nistri</surname><given-names>A</given-names></name></person-group><article-title>Neuroprotective effect of propofol against excitotoxic injury to locomotor networks of the rat spinal cord in vitro</article-title><source>Eur J Neurosci</source><year>2016</year><volume>44</volume><fpage>2418</fpage><lpage>2430</lpage><pub-id pub-id-type="pmid">27468970</pub-id>
</element-citation></ref><ref id="R18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mi</surname><given-names>J</given-names></name>
<name><surname>Yang</surname><given-names>Y</given-names></name>
<name><surname>Yao</surname><given-names>H</given-names></name>
<etal/></person-group><article-title>Inhibition of heat shock protein family A member 8 attenuates spinal cord ischemia-reperfusion injury via astrocyte NF-&#x003ba;B/NLRP3 inflammasome pathway : HSPA8 inhibition protects spinal ischemia-reperfusion injury</article-title><source>J Neuroinflammation</source><year>2021</year><volume>18</volume><fpage>170</fpage><pub-id pub-id-type="pmid">34362408</pub-id>
</element-citation></ref><ref id="R19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>J</given-names></name>
<name><surname>Huang</surname><given-names>G</given-names></name>
<name><surname>Zhang</surname><given-names>K</given-names></name>
<etal/></person-group><article-title>Nrf2 activation in astrocytes contributes to spinal cord ischemic tolerance induced by hyperbaric oxygen preconditioning</article-title><source>J Neurotrauma</source><year>2014</year><volume>31</volume><fpage>1343</fpage><lpage>1353</lpage><pub-id pub-id-type="pmid">24716787</pub-id>
</element-citation></ref><ref id="R20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>XQ</given-names></name>
<name><surname>Yu</surname><given-names>Q</given-names></name>
<name><surname>Zhang</surname><given-names>ZL</given-names></name>
<name><surname>Sun</surname><given-names>XJ</given-names></name>
<name><surname>Ma</surname><given-names>H</given-names></name></person-group><article-title>MiR-187-3p mimic alleviates ischemia-reperfusion-induced pain hypersensitivity through inhibiting spinal P2X7R and subsequent mature IL-1&#x003b2; release in mice</article-title><source>Brain BehavImmun</source><year>2019</year><volume>79</volume><fpage>91</fpage><lpage>101</lpage></element-citation></ref><ref id="R21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hern&#x000e1;ndez</surname><given-names>DE</given-names></name>
<name><surname>Salvadores</surname><given-names>NA</given-names></name>
<name><surname>Moya-Alvarado</surname><given-names>G</given-names></name>
<name><surname>Catal&#x000e1;n</surname><given-names>RJ</given-names></name>
<name><surname>Bronfman</surname><given-names>FC</given-names></name>
<name><surname>Court</surname><given-names>FA</given-names></name></person-group><article-title>Axonal degeneration induced by glutamate excitotoxicity is mediated by necroptosis</article-title><source>J Cell Sci</source><year>2018</year><volume>131</volume><fpage>jcs214684</fpage><pub-id pub-id-type="pmid">30333135</pub-id>
</element-citation></ref><ref id="R22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wen</surname><given-names>SY</given-names></name>
<name><surname>Li</surname><given-names>AM</given-names></name>
<name><surname>Mi</surname><given-names>KQ</given-names></name>
<etal/></person-group><article-title>In vitro neuroprotective effects of ciliary neurotrophic factor on dorsal root ganglion neurons with glutamate-induced neurotoxicity</article-title><source>Neural Regen Res</source><year>2017</year><volume>12</volume><fpage>1716</fpage><lpage>1723</lpage><pub-id pub-id-type="pmid">29171438</pub-id>
</element-citation></ref><ref id="R23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vanzulli</surname><given-names>I</given-names></name>
<name><surname>Butt</surname><given-names>AM</given-names></name></person-group><article-title>mGluR5 protect astrocytes from ischemic damage in postnatal CNS white matter</article-title><source>Cell Calcium</source><year>2015</year><volume>58</volume><fpage>423</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">26189008</pub-id>
</element-citation></ref><ref id="R24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palmer</surname><given-names>AM</given-names></name>
<name><surname>Marion</surname><given-names>DW</given-names></name>
<name><surname>Botscheller</surname><given-names>ML</given-names></name>
<name><surname>Bowen</surname><given-names>DM</given-names></name>
<name><surname>DeKosky</surname><given-names>ST</given-names></name></person-group><article-title>Increased transmitter amino acid concentration in human ventricular CSF after brain trauma</article-title><source>Neuroreport</source><year>1994</year><volume>6</volume><fpage>153</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">7703404</pub-id>
</element-citation></ref><ref id="R25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hayes</surname><given-names>RL</given-names></name>
<name><surname>Jenkins</surname><given-names>LW</given-names></name>
<name><surname>Lyeth</surname><given-names>BG</given-names></name></person-group><article-title>Neurotransmitter-mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids</article-title><source>J Neurotrauma</source><year>1992</year><volume>9</volume><issue>Suppl 1</issue><fpage>S173</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">1350312</pub-id>
</element-citation></ref><ref id="R26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Olney</surname><given-names>JW</given-names></name></person-group><article-title>Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate</article-title><source>Science</source><year>1969</year><volume>164</volume><fpage>719</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">5778021</pub-id>
</element-citation></ref><ref id="R27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kristi&#x000e1;n</surname><given-names>T</given-names></name>
<name><surname>Siesj&#x000f6;</surname><given-names>BK</given-names></name></person-group><article-title>Calcium in ischemic cell death</article-title><source>Stroke</source><year>1998</year><volume>29</volume><fpage>705</fpage><lpage>718</lpage><pub-id pub-id-type="pmid">9506616</pub-id>
</element-citation></ref><ref id="R28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alizadeh</surname><given-names>A</given-names></name>
<name><surname>Dyck</surname><given-names>SM</given-names></name>
<name><surname>Karimi-Abdolrezaee</surname><given-names>S</given-names></name></person-group><article-title>Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms</article-title><source>Front Neurol</source><year>2019</year><volume>10</volume><fpage>282</fpage><pub-id pub-id-type="pmid">30967837</pub-id>
</element-citation></ref><ref id="R29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hall</surname><given-names>ED</given-names></name></person-group><article-title>Antioxidant therapies for acute spinal cord injury</article-title><source>Neurotherapeutics</source><year>2011</year><volume>8</volume><fpage>152</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">21424941</pub-id>
</element-citation></ref><ref id="R30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Quadri</surname><given-names>SA</given-names></name>
<name><surname>Farooqui</surname><given-names>M</given-names></name>
<name><surname>Ikram</surname><given-names>A</given-names></name>
<etal/></person-group><article-title>Recent update on basic mechanisms of spinal cord injury</article-title><source>Neurosurg Rev</source><year>2020</year><volume>43</volume><fpage>425</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">29998371</pub-id>
</element-citation></ref><ref id="R31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borgens</surname><given-names>RB</given-names></name>
<name><surname>Liu-Snyder</surname><given-names>P</given-names></name></person-group><article-title>Understanding secondary injury</article-title><source>Q Rev Biol</source><year>2012</year><volume>87</volume><fpage>89</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">22696939</pub-id>
</element-citation></ref><ref id="R32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>HJ</given-names></name>
<name><surname>Wu</surname><given-names>C</given-names></name>
<name><surname>Niu</surname><given-names>HJ</given-names></name>
<etal/></person-group><article-title>Neuroprotective Mechanisms of melatonin in hemorrhagic stroke</article-title><source>Cell Mol Neurobiol</source><year>2017</year><volume>37</volume><fpage>1173</fpage><lpage>1185</lpage><pub-id pub-id-type="pmid">28132129</pub-id>
</element-citation></ref><ref id="R33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Watson</surname><given-names>N</given-names></name>
<name><surname>Diamandis</surname><given-names>T</given-names></name>
<name><surname>Gonzales-Portillo</surname><given-names>C</given-names></name>
<name><surname>Reyes</surname><given-names>S</given-names></name>
<name><surname>Borlongan</surname><given-names>CV</given-names></name></person-group><article-title>Melatonin as an antioxidant for stroke neuroprotection</article-title><source>Cell Transplant</source><year>2016</year><volume>25</volume><fpage>883</fpage><lpage>891</lpage><pub-id pub-id-type="pmid">26497887</pub-id>
</element-citation></ref><ref id="R34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adams</surname><given-names>KL</given-names></name>
<name><surname>Gallo</surname><given-names>V</given-names></name></person-group><article-title>The diversity and disparity of the glial scar</article-title><source>Nat Neurosci</source><year>2018</year><volume>21</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">29269757</pub-id>
</element-citation></ref><ref id="R35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>MA</given-names></name></person-group><article-title>Targeting central nervous system regeneration with cell type specificity</article-title><source>Neurosurg Clin N Am</source><year>2021</year><volume>32</volume><fpage>397</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">34053727</pub-id>
</element-citation></ref><ref id="R36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kjell</surname><given-names>J</given-names></name>
<name><surname>Olson</surname><given-names>L</given-names></name></person-group><article-title>Rat models of spinal cord injury: from pathology to potential therapies</article-title><source>Dis Model Mech</source><year>2016</year><volume>9</volume><fpage>1125</fpage><lpage>1137</lpage><pub-id pub-id-type="pmid">27736748</pub-id>
</element-citation></ref><ref id="R37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O'Shea</surname><given-names>TM</given-names></name>
<name><surname>Burda</surname><given-names>JE</given-names></name>
<name><surname>Sofroniew</surname><given-names>MV</given-names></name></person-group><article-title>Cell biology of spinal cord injury and repair</article-title><source>J Clin Invest</source><year>2017</year><volume>127</volume><fpage>3259</fpage><lpage>3270</lpage><pub-id pub-id-type="pmid">28737515</pub-id>
</element-citation></ref><ref id="R38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dias</surname><given-names>DO</given-names></name>
<name><surname>G&#x000f6;ritz</surname><given-names>C</given-names></name></person-group><article-title>Fibrotic scarring following lesions to the central nervous system</article-title><source>Matrix Biol</source><year>2018</year><volume>68-69</volume><fpage>561</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">29428230</pub-id>
</element-citation></ref><ref id="R39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dyck</surname><given-names>SM</given-names></name>
<name><surname>Karimi-Abdolrezaee</surname><given-names>S</given-names></name></person-group><article-title>Chondroitin sulfate proteoglycans: key modulators in the developing and pathologic central nervous system</article-title><source>Exp Neurol</source><year>2015</year><volume>269</volume><fpage>169</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">25900055</pub-id>
</element-citation></ref><ref id="R40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tran</surname><given-names>AP</given-names></name>
<name><surname>Warren</surname><given-names>PM</given-names></name>
<name><surname>Silver</surname><given-names>J</given-names></name></person-group><article-title>New insights into glial scar formation after spinal cord injury</article-title><source>Cell Tissue Res</source><year>2022</year><volume>387</volume><fpage>319</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">34076775</pub-id>
</element-citation></ref><ref id="R41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Siebert</surname><given-names>JR</given-names></name>
<name><surname>Osterhout</surname><given-names>DJ</given-names></name></person-group><article-title>Select neurotrophins promote oligodendrocyte progenitor cell process outgrowth in the presence of chondroitin sulfate proteoglycans</article-title><source>J Neurosci Res</source><year>2021</year><volume>99</volume><fpage>1009</fpage><lpage>1023</lpage><pub-id pub-id-type="pmid">33453083</pub-id>
</element-citation></ref><ref id="R42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lang</surname><given-names>BT</given-names></name>
<name><surname>Cregg</surname><given-names>JM</given-names></name>
<name><surname>DePaul</surname><given-names>MA</given-names></name>
<etal/></person-group><article-title>Modulation of the proteoglycan receptor PTP&#x003c3; promotes recovery after spinal cord injury</article-title><source>Nature</source><year>2015</year><volume>518</volume><fpage>404</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">25470046</pub-id>
</element-citation></ref><ref id="R43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hussein</surname><given-names>RK</given-names></name>
<name><surname>Mencio</surname><given-names>CP</given-names></name>
<name><surname>Katagiri</surname><given-names>Y</given-names></name>
<name><surname>Brake</surname><given-names>AM</given-names></name>
<name><surname>Geller</surname><given-names>HM</given-names></name></person-group><article-title>Role of chondroitin sulfation following spinal cord injury</article-title><source>Front Cell Neurosci</source><year>2020</year><volume>14</volume><fpage>208</fpage><pub-id pub-id-type="pmid">32848612</pub-id>
</element-citation></ref><ref id="R44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Visavadiya</surname><given-names>NP</given-names></name>
<name><surname>Patel</surname><given-names>SP</given-names></name>
<name><surname>VanRooyen</surname><given-names>JL</given-names></name>
<name><surname>Sullivan</surname><given-names>PG</given-names></name>
<name><surname>Rabchevsky</surname><given-names>AG</given-names></name></person-group><article-title>Cellular and subcellular oxidative stress parameters following severe spinal cord injury</article-title><source>Redox Biol</source><year>2016</year><volume>8</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">26760911</pub-id>
</element-citation></ref><ref id="R45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kigerl</surname><given-names>KA</given-names></name>
<name><surname>McGaughy</surname><given-names>VM</given-names></name>
<name><surname>Popovich</surname><given-names>PG</given-names></name></person-group><article-title>Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury</article-title><source>J Comp Neurol</source><year>2006</year><volume>494</volume><fpage>578</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">16374800</pub-id>
</element-citation></ref><ref id="R46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rossignol</surname><given-names>S</given-names></name>
<name><surname>Schwab</surname><given-names>M</given-names></name>
<name><surname>Schwartz</surname><given-names>M</given-names></name>
<name><surname>Fehlings</surname><given-names>MG</given-names></name></person-group><article-title>Spinal cord injury: time to move?</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>11782</fpage><lpage>11792</lpage><pub-id pub-id-type="pmid">17978014</pub-id>
</element-citation></ref><ref id="R47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghasemlou</surname><given-names>N</given-names></name>
<name><surname>Bouhy</surname><given-names>D</given-names></name>
<name><surname>Yang</surname><given-names>J</given-names></name>
<etal/></person-group><article-title>Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injury</article-title><source>Brain</source><year>2010</year><volume>133</volume><fpage>126</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">20047904</pub-id>
</element-citation></ref><ref id="R48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weng</surname><given-names>Q</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<etal/></person-group><article-title>Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization</article-title><source>Cell Death Dis</source><year>2018</year><volume>9</volume><fpage>251</fpage><pub-id pub-id-type="pmid">29445144</pub-id>
</element-citation></ref><ref id="R49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheyuo</surname><given-names>C</given-names></name>
<name><surname>Wu</surname><given-names>R</given-names></name>
<name><surname>Zhou</surname><given-names>M</given-names></name>
<name><surname>Jacob</surname><given-names>A</given-names></name>
<name><surname>Coppa</surname><given-names>G</given-names></name>
<name><surname>Wang</surname><given-names>P</given-names></name></person-group><article-title>Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve</article-title><source>Shock</source><year>2011</year><volume>35</volume><fpage>258</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">20720512</pub-id>
</element-citation></ref><ref id="R50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Gu</surname><given-names>J</given-names></name>
<name><surname>Liu</surname><given-names>Y</given-names></name>
<etal/></person-group><article-title>iNOS participates in apoptosis of spinal cord neurons via p-BAD dephosphorylation following isch-emia/reperfusion (I/R) injury in rat spinal cord</article-title><source>Neurosci Lett</source><year>2013</year><volume>545</volume><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">23643992</pub-id>
</element-citation></ref><ref id="R51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hamada</surname><given-names>Y</given-names></name>
<name><surname>Ikata</surname><given-names>T</given-names></name>
<name><surname>Katoh</surname><given-names>S</given-names></name>
<etal/></person-group><article-title>Roles of nitric oxide in compression injury of rat spinal cord</article-title><source>Free Radic Biol Med</source><year>1996</year><volume>20</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8903674</pub-id>
</element-citation></ref><ref id="R52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Est&#x000e9;vez</surname><given-names>AG</given-names></name>
<name><surname>Spear</surname><given-names>N</given-names></name>
<name><surname>Manuel</surname><given-names>SM</given-names></name>
<etal/></person-group><article-title>Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation</article-title><source>J Neurosci</source><year>1998</year><volume>18</volume><fpage>923</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">9437014</pub-id>
</element-citation></ref><ref id="R53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>LL</given-names></name>
<name><surname>Zhao</surname><given-names>XC</given-names></name>
<name><surname>Yan</surname><given-names>LF</given-names></name>
<etal/></person-group><article-title>C-jun phosphorylation contributes to down regulation of neuronal nitric oxide synthase protein and motoneurons death in injured spinal cords following root-avulsion of the brachial plexus</article-title><source>Neuroscience</source><year>2011</year><volume>189</volume><fpage>397</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">21596101</pub-id>
</element-citation></ref><ref id="R54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>J</given-names></name>
<name><surname>Kim</surname><given-names>GM</given-names></name>
<name><surname>Chen</surname><given-names>S</given-names></name>
<etal/></person-group><article-title>iNOS and nitrotyrosine expression after spinal cord injury</article-title><source>J Neurotrauma</source><year>2001</year><volume>18</volume><fpage>523</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">11393255</pub-id>
</element-citation></ref><ref id="R55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kiziltepe</surname><given-names>U</given-names></name>
<name><surname>Turan</surname><given-names>NN</given-names></name>
<name><surname>Han</surname><given-names>U</given-names></name>
<name><surname>Ulus</surname><given-names>AT</given-names></name>
<name><surname>Akar</surname><given-names>F</given-names></name></person-group><article-title>Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury</article-title><source>J Vasc Surg</source><year>2004</year><volume>40</volume><fpage>138</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">15218474</pub-id>
</element-citation></ref><ref id="R56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>SR</given-names></name>
<name><surname>Jin</surname><given-names>XG</given-names></name>
<name><surname>Pan</surname><given-names>HL</given-names></name></person-group><article-title>Endogenous nitric oxide inhibits spinal NMDA receptor activity and pain hypersensitivity induced by nerve injury</article-title><source>Neuropharmacology</source><year>2017</year><volume>125</volume><fpage>156</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">28754372</pub-id>
</element-citation></ref><ref id="R57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ilhan</surname><given-names>A</given-names></name>
<name><surname>Koltuksuz</surname><given-names>U</given-names></name>
<name><surname>Ozen</surname><given-names>S</given-names></name>
<name><surname>Uz</surname><given-names>E</given-names></name>
<name><surname>Ciralik</surname><given-names>H</given-names></name>
<name><surname>Akyol</surname><given-names>O</given-names></name></person-group><article-title>The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits</article-title><source>Eur J Cardiothorac Surg</source><year>1999</year><volume>16</volume><fpage>458</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">10571095</pub-id>
</element-citation></ref><ref id="R58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bao</surname><given-names>F</given-names></name>
<name><surname>Liu</surname><given-names>D</given-names></name></person-group><article-title>Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits</article-title><source>Neuroscience</source><year>2002</year><volume>115</volume><fpage>839</fpage><lpage>849</lpage><pub-id pub-id-type="pmid">12435422</pub-id>
</element-citation></ref><ref id="R59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Conti</surname><given-names>A</given-names></name>
<name><surname>Miscusi</surname><given-names>M</given-names></name>
<name><surname>Cardali</surname><given-names>S</given-names></name>
<etal/></person-group><article-title>Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation</article-title><source>Brain Res Rev</source><year>2007</year><volume>54</volume><fpage>205</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">17500094</pub-id>
</element-citation></ref><ref id="R60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wallace</surname><given-names>JL</given-names></name>
<name><surname>Wang</surname><given-names>R</given-names></name></person-group><article-title>Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter</article-title><source>Nat Rev Drug Discov</source><year>2015</year><volume>14</volume><fpage>329</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">25849904</pub-id>
</element-citation></ref><ref id="R61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>C</given-names></name>
<name><surname>Zhang</surname><given-names>M</given-names></name>
<name><surname>Zhang</surname><given-names>G</given-names></name>
<name><surname>Yan</surname><given-names>S</given-names></name>
<name><surname>Yan</surname><given-names>W</given-names></name></person-group><article-title>Hydrogen sulfide improves functional recovery in rat traumatic spinal cord injury model by inducing nuclear translocation of NF-E2-related factor 2</article-title><source>Biol Pharm Bull</source><year>2021</year><volume>44</volume><fpage>1093</fpage><lpage>1100</lpage><pub-id pub-id-type="pmid">34334495</pub-id>
</element-citation></ref><ref id="R62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xie</surname><given-names>L</given-names></name>
<name><surname>Yu</surname><given-names>S</given-names></name>
<name><surname>Yang</surname><given-names>K</given-names></name>
<name><surname>Li</surname><given-names>C</given-names></name>
<name><surname>Liang</surname><given-names>Y</given-names></name></person-group><article-title>Hydrogen sulfide inhibits autophagic neuronal cell death by reducing oxidative stress in spinal cord ischemia reperfusion injury</article-title><source>Oxid Med Cell Longev</source><year>2017</year><volume>2017</volume><fpage>8640284</fpage><pub-id pub-id-type="pmid">28685010</pub-id>
</element-citation></ref><ref id="R63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y</given-names></name>
<name><surname>Pan</surname><given-names>L</given-names></name>
<name><surname>Jiang</surname><given-names>A</given-names></name>
<name><surname>Yin</surname><given-names>M</given-names></name></person-group><article-title>Hydrogen sulfide upregulated ln-cRNA CasC7 to reduce neuronal cell apoptosis in spinal cord ischemia-reperfusion injury rat</article-title><source>Biomed Pharmacother</source><year>2018</year><volume>98</volume><fpage>856</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">29571256</pub-id>
</element-citation></ref><ref id="R64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>H</given-names></name>
<name><surname>Xiao</surname><given-names>J</given-names></name>
<name><surname>Kang</surname><given-names>B</given-names></name>
<name><surname>Zhu</surname><given-names>X</given-names></name>
<name><surname>Xin</surname><given-names>N</given-names></name>
<name><surname>Wang</surname><given-names>Z</given-names></name></person-group><article-title>PI3K/SGK1/ GSK3&#x003b2; signaling pathway is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide</article-title><source>Exp Cell Res</source><year>2016</year><volume>345</volume><fpage>134</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">26163895</pub-id>
</element-citation></ref><ref id="R65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abe</surname><given-names>K</given-names></name>
<name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>The possible role of hydrogen sulfide as an endogenous neuromodulator</article-title><source>J Neurosci</source><year>1996</year><volume>16</volume><fpage>1066</fpage><lpage>1071</lpage><pub-id pub-id-type="pmid">8558235</pub-id>
</element-citation></ref><ref id="R66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>L</given-names></name>
<name><surname>Jiang</surname><given-names>HK</given-names></name>
<name><surname>Li</surname><given-names>YP</given-names></name>
<name><surname>Guo</surname><given-names>YP</given-names></name></person-group><article-title>Hydrogen sulfide protects spinal cord and induces autophagy via miR-30c in a rat model of spinal cord ischemia-reperfusion injury</article-title><source>J Biomed Sci</source><year>2015</year><volume>22</volume><fpage>50</fpage><pub-id pub-id-type="pmid">26149869</pub-id>
</element-citation></ref><ref id="R67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>X</given-names></name>
<name><surname>Hao</surname><given-names>D</given-names></name>
<name><surname>Zhang</surname><given-names>H</given-names></name>
<name><surname>Liu</surname><given-names>B</given-names></name>
<name><surname>Yang</surname><given-names>M</given-names></name>
<name><surname>He</surname><given-names>B</given-names></name></person-group><article-title>Treatment with hydrogen sulfide attenuates sublesional skeletal deterioration following motor complete spinal cord injury in rats</article-title><source>Osteoporos Int</source><year>2017</year><volume>28</volume><fpage>687</fpage><lpage>695</lpage><pub-id pub-id-type="pmid">27591786</pub-id>
</element-citation></ref><ref id="R68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kakinohana</surname><given-names>M</given-names></name>
<name><surname>Marutani</surname><given-names>E</given-names></name>
<name><surname>Tokuda</surname><given-names>K</given-names></name>
<etal/></person-group><article-title>Breathing hydrogen sulfide prevents delayed paraplegia in mice</article-title><source>Free Radic Biol Med</source><year>2019</year><volume>131</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">30529602</pub-id>
</element-citation></ref><ref id="R69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H</given-names></name>
<name><surname>Wu</surname><given-names>Y</given-names></name>
<name><surname>Han</surname><given-names>W</given-names></name>
<etal/></person-group><article-title>Hydrogen sulfide ameliorates blood-spinal cord barrier disruption and improves functional recovery by inhibiting endoplasmic reticulum stress-dependent autophagy</article-title><source>Front Pharmacol</source><year>2018</year><volume>9</volume><fpage>858</fpage><pub-id pub-id-type="pmid">30210332</pub-id>
</element-citation></ref><ref id="R70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Campolo</surname><given-names>M</given-names></name>
<name><surname>Esposito</surname><given-names>E</given-names></name>
<name><surname>Ahmad</surname><given-names>A</given-names></name>
<name><surname>Di</surname><given-names>Paola R</given-names></name>
<name><surname>Wallace</surname><given-names>JL</given-names></name>
<name><surname>Cuz-zocrea</surname><given-names>S</given-names></name></person-group><article-title>A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury</article-title><source>FASEB J</source><year>2013</year><volume>27</volume><fpage>4489</fpage><lpage>4499</lpage><pub-id pub-id-type="pmid">23901068</pub-id>
</element-citation></ref><ref id="R71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Petrova</surname><given-names>V</given-names></name>
<name><surname>Eva</surname><given-names>R</given-names></name></person-group><article-title>The virtuous cycle of axon growth: axonal transport of growth-promoting machinery as an intrinsic determinant of axon regeneration</article-title><source>Dev Neurobiol</source><year>2018</year><volume>78</volume><fpage>898</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">29989351</pub-id>
</element-citation></ref><ref id="R72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hou</surname><given-names>H</given-names></name>
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Tang</surname><given-names>P</given-names></name></person-group><article-title>Acute spinal cord injury in rats should target activated autophagy</article-title><source>J Neurosurg Spine</source><year>2014</year><volume>20</volume><fpage>568</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">24559459</pub-id>
</element-citation></ref><ref id="R73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matsui</surname><given-names>Y</given-names></name>
<name><surname>Takagi</surname><given-names>H</given-names></name>
<name><surname>Qu</surname><given-names>X</given-names></name>
<etal/></person-group><article-title>Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy</article-title><source>Circ Res</source><year>2007</year><volume>100</volume><fpage>914</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">17332429</pub-id>
</element-citation></ref><ref id="R74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rami</surname><given-names>A</given-names></name>
<name><surname>Langhagen</surname><given-names>A</given-names></name>
<name><surname>Steiger</surname><given-names>S</given-names></name></person-group><article-title>Focal cerebral ischemia induces upregulation of Beclin 1 and autophagy-like cell death</article-title><source>Neurobiol Dis</source><year>2008</year><volume>29</volume><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">17936001</pub-id>
</element-citation></ref><ref id="R75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>Y</given-names></name>
<name><surname>Goto</surname><given-names>Y</given-names></name>
<name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria</article-title><source>Antioxid Redox Signal</source><year>2010</year><volume>12</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">19852698</pub-id>
</element-citation></ref><ref id="R76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bellezza</surname><given-names>I</given-names></name>
<name><surname>Giambanco</surname><given-names>I</given-names></name>
<name><surname>Minelli</surname><given-names>A</given-names></name>
<name><surname>Donato</surname><given-names>R</given-names></name></person-group><article-title>Nrf2-Keap1 signaling in oxidative and reductive stress</article-title><source>Biochim Biophys Acta Mol Cell Res</source><year>2018</year><volume>1865</volume><fpage>721</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">29499228</pub-id>
</element-citation></ref><ref id="R77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wagner</surname><given-names>F</given-names></name>
<name><surname>Asfar</surname><given-names>P</given-names></name>
<name><surname>Calzia</surname><given-names>E</given-names></name>
<name><surname>Radermacher</surname><given-names>P</given-names></name>
<name><surname>Szab&#x000f3;</surname><given-names>C</given-names></name></person-group><article-title>Bench-to-bedside review: hydrogen sulfide--the third gaseous transmitter: applications for critical care</article-title><source>Crit Care</source><year>2009</year><volume>13</volume><fpage>213</fpage><pub-id pub-id-type="pmid">19519960</pub-id>
</element-citation></ref><ref id="R78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Minamishima</surname><given-names>S</given-names></name>
<name><surname>Bougaki</surname><given-names>M</given-names></name>
<name><surname>Sips</surname><given-names>PY</given-names></name>
<etal/></person-group><article-title>Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice</article-title><source>Circulation</source><year>2009</year><volume>120</volume><fpage>888</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">19704099</pub-id>
</element-citation></ref><ref id="R79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lefer</surname><given-names>DJ</given-names></name></person-group><article-title>A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>17907</fpage><lpage>17908</lpage><pub-id pub-id-type="pmid">17991773</pub-id>
</element-citation></ref></ref-list></back></article>